跳至主要内容
临床试验/NCT01895153
NCT01895153已完成不适用

The Efficacy of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy in Patients With Bladder Pain Syndrome

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
1
主要终点
the change of IC-Q symptom index(ICSI)score from baseline to 6 months after each treatment

研究概览

简要总结

The efficacy of pentosan polysulfate sodium, hydrodistension and combination therapy in patients with bladder pain syndrome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • men and women who were over 18 years old and had symptoms over 6 months.
  • 4 or more with an pain visual analogue score
  • 12 or more O'Leary-Sant Intersttial Cystitis questionnaire (IC-Q) symptom and problem score and with a pain score and nocturia score of 2 or more.

排除标准

  • history of hydrodistention,augumentation cystoplasty due to IC/BPS
  • pentosan polysulfate sodium (Elmiron) history over 1 month within 6 months.
  • Women of child-bearing potential who were pregnant or nursing
  • mean voided volume lesser than 40ml or over than 400ml.
  • hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.
  • urinary tract infection during run-in periods.
  • genitourinary tuberculosis or bladder,urethral and prostate cancer
  • recurrent urinary tract infection
  • history of hystrectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate opreation or treatment etc within 6months.
  • neurologic disease history of cerebral infaction,multiple sclerosis or parkinsonism etc.

结局指标

主要结局

the change of IC-Q symptom index(ICSI)score from baseline to 6 months after each treatment

时间窗: 6months

次要结局

  • The change of voiding dairy parameters(mean number of micturition,Urgency etc) after each treatment.(1,2,4 and 6months after each treatment .)
  • The change of Global Response Assessment(GRA) score(1,2,4 and 6months after each treatment .)
  • The change of O'Leary-Sant Intersttial Cystitis questionnaire (IC-Q)score after each treatment(1,2,4 and 6months after each treatment .)
  • The estimation of safty and Complications for each treatment(1,2,4 and 6months after each treatment .)
  • The change of EQ-5D Health Questionnaire score(1,2,4 and 6months after each treatment .)
  • The change of Brief Pain Inventory-short form(BPI-sf) score(1 and 6months after each treatment.)
  • The change of Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF)(1,2,4 and 6months after each treatment .)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

KYU-SUNG LEE

professor,MD,PhD

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验